Markus von Deimling
@mvdeimling
MD, resident in urology @UKEHamburg | former research fellow @Uro_MedUniWien @MedUni_Wien | views are on my own
ID: 1488829210886037506
02-02-2022 10:59:16
64 Tweet
137 Followers
211 Following
Neutrophil-to-lymphocyte ratio as a potential biomarker in patients with localized #UrothelialCarcinoma treated with chemotherapy. #ExpertCommentary Dr. Bishoy M. Faltas WCM Englander Institute for Precision Medicine discusses work from von Deimling et al. on UroToday > bit.ly/3Lt3Sr7 Markus von Deimling Shahrokh F. Shariat
Carboplatin vs cisplatin-based chemotherapy for lymph node-positive #BladderCancer. #ExpertCommentary Dr. Bishoy M. Faltas WCM Englander Institute for Precision Medicine discusses work by von Deimling et al. in European Urology > bit.ly/42AaVDL Markus von Deimling Laura S. Mertens
Neutrophil-to-lymphocyte ratio as a potential biomarker in patients with localized #UrothelialCarcinoma treated with chemotherapy. #ExpertCommentary Dr. Bishoy M. Faltas WCM Englander Institute for Precision Medicine discusses work from von Deimling et al. on UroToday > bit.ly/3Lt3Sr7 Markus von Deimling Shahrokh F. Shariat
Carboplatin vs cisplatin-based chemotherapy for lymph node-positive #BladderCancer. #ExpertCommentary Dr. Bishoy M. Faltas WCM Englander Institute for Precision Medicine discusses work by von Deimling et al. in European Urology > bit.ly/42AaVDL Markus von Deimling Laura S. Mertens
Carboplatin vs cisplatin-based chemotherapy for lymph node-positive #BladderCancer. #ExpertCommentary Dr. Bishoy M. Faltas WCM Englander Institute for Precision Medicine discusses work by von Deimling et al. in European Urology > bit.ly/42AaVDL Markus von Deimling Laura S. Mertens
Online Now: Impact of the Extent of Lymph Node Dissection on Survival Outcomes in Clinically Lymph Node-Positive #BladderCancer by Markus von Deimling et al. doi.org/10.1111/bju.16…
We need procedure-specific comorbidity assessments, as standard comorbidity indices are too generic to predict postop. morbidity! Check out our latest paper authors.elsevier.com/a/1iOuo5YR3Cap… Malte W. Vetterlein Shahrokh F. Shariat Michael Rink Jakob Klemm Mara Koelker Victor Schuettfort frederikkoenig Philipp Gild
In cN+ #BladderCancer treated with cisplatin-based induction CTX followed by RC we found no difference in #PathologicalResponse and OS/CSS between delivering three and four cycles - Markus von Deimling Laura S. Mertens et al doi.org/10.1111/bju.16…
First-line immunotherapy of metastatic renal cell carcinoma: an updated network meta-analysis including triplet therapy Takafumi Yanagisawa Ekaterina Laukhtina Tatsushi Kawada Shahrokh F. Shariat Manuela Schmidinger doi.org/10.1111/bju.16…
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive #BladderCancer. #BeyondTheAbstract with Markus von Deimling, and Shahrokh F. Shariat. #ReadNow on UroToday > bit.ly/4cgbGHU BJU International #CLIPOLY
Impact of the extent of lymph node dissection on survival outcomes in clinically lymph node-positive #BladderCancer. #BeyondTheAbstract with Markus von Deimling, and Shahrokh F. Shariat. #ReadNow on UroToday > bit.ly/4cgbGHU BJU International #CLIPOLY
Welcoming the reconstructive urology community to Hamburg! Prof. Margit Fisch kicks off IMORU IX UKE Hamburg with live and semi-live surgeries on genitourinary complications. Jill C. Buckley presents a sophisticated algorithm for managing radiogenic strictures & stenoses. #IMORU
Jill C. Buckley sharing her roadmap for decision making around radiation-associated urethral stricture management - Very Useful! #IMORU25
Great talk by Tamsin Greenwell on a rare but important topic — female urethral reconstruction. World-class experts sharing their experience in live and semi-live surgeries at IMORU XI in #Hamburg. Congrats, Tamsin! #Urology #Urethroplasty #IMORUXI